MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹155 Cr | ₹123 Cr | ₹98 Cr | ₹80 Cr | ₹72 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹72 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 25.94 | |
| Mar2024 | ₹123 Cr | 25.78 | |
| Mar2023 | ₹98 Cr | 22.36 | |
| Mar2022 | ₹80 Cr | 10.74 | |
| Mar2021 | ₹72 Cr | - | |
Compare Long Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,912.3 Cr | -0.3% | 7.9% | 8.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.3% |
7.9% |
8.4% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses